EGFR (Epidermal Growth Factor Receptor)
EGFR
Receptor tyrosine kinase driving cell proliferation, commonly mutated in NSCLC.
Функция
Activating mutations drive oncogenic signaling. Targeted by TKIs (erlotinib, osimertinib) and antibodies (cetuximab).
Препараты, действующие на данную мишень
| Препарат | Действие | Первичный |
|---|---|---|
| Trastuzumab | Antagonist | Да |